Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2024-10-22 00:00:00 ET · period of report 2024-10-18 · accession 0000950170-24-116345 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-10-22 | 2024-10-18+ | TYRA | Harris Todd | Pres, CEO, Dir | S - Sale | $27.28 | -62.7K | 1.37M | -4% | -$1.71M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-21 | S | D | 13,188 | $28.16 | 1,355,927 | D | — | — | (F4) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $27.8957 to $28.5951. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 2 | Common | Common Stock | 2024-10-18 | S | D | 43,636 | $27.01 | 1,375,011 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.60 to $27.51. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| 3 | Common | Common Stock | 2024-10-21 | S | D | 5,896 | $27.32 | 1,369,115 | D | — | — | (F3) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $26.89 to $27.84. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |